Breaking News

You are here » Indian-Commodity  :  Equity & Shares  :  Dr. Reddy's Lab shines on launching Neostigmine Methylsulfate Injection in US

14-Sep2018

Dr. Reddy's Lab shines on launching Neostigmine Methylsulfate Injection in US

Dr. Reddys Laboratories is currently trading at Rs. 2569.00, up by 39.70 points or 1.57% from its previous closing of Rs. 2529.30 on the BSE.

The scrip opened at Rs. 2540.05 and has touched a high and low of Rs. 2593.65 and Rs. 2540.05 respectively. So far 28658 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2660.10 on 10-Sep-2018 and a 52 week low of Rs. 1888.00 on 21-May-2018.

Last one week high and low of the scrip stood at Rs. 2660.10 and Rs. 2490.55 respectively. The current market cap of the company is Rs. 42902.95 crore.

The promoters holding in the company stood at 26.79%, while Institutions and Non-Institutions held 44.27% and 14.60% respectively.

Dr. Reddy's Laboratories has launched Neostigmine Methylsulfate Injection, USP, a therapeutic equivalent generic version of Bloxiverz (Neostigmine Methylsulfate) Injection in the US market, approved by the US Food and Drug Administration (USFDA).

The Bloxiverz brand and generic had US sales of approximately $111 million MAT for the most recent twelve months ending in July 2018 according to IMS Health. Dr. Reddy's Neostigmine Methylsulfate Injection, USP is available in 5 mg/10 ml and 10 mg/10 ml multi-dose vials.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Related News

View all news

Reliance Industries slips despite reporting 10% rise in Q4 consolidated net profit

Reliance Industries is currently trading at Rs. 1356.35, down by 26.55 points or 1.92% from its previous closing of Rs. 1382.90 on the BSE.The scrip opened at Rs. 1364.00 and has touched a high and low......

Future Retail trades in green on the BSE

Future Retail is currently trading at Rs. 430.80, up by 0.75 points or 0.17% from its previous closing of Rs. 430.05 on the BSE.The scrip opened at Rs. 430.00 and has touched a high and low of Rs. 435.15......

GVK Power zooms with its arms inking pact with ADIA, NIIF

GVK Power & Infrastructure is currently trading at Rs. 7.98, up by 0.66 points or 9.02% from its previous closing of Rs. 7.32 on the BSE.The scrip opened at Rs. 7.74 and has touched a high and......

Top News

View all news

Bank of Baroda's board to consider issuance of equity shares of Rs 5,042 crore to Govt

Bank of Baroda's board is going to consider issuance of equity shares of Rs 5,042 crore to Government of India on a Preferential Basis. The meeting of the Board of Directors of the Bank is scheduled to......

Gujarat Petrosynthese to invest surplus funds in mutual funds, bonds, securities, shares

Gujarat Petrosynthese has received an approval to invest surplus funds in mutual funds, bonds, securities, shares, inter corporate deposits etc. to optimize its returns. The Board of Directors of the Company......

Reliance's Retail Unit delivers record-breaking performance in revenue, profits during FY19

Reliance Industries' Retail Unit--Reliance Retail has delivered a record-breaking performance in revenue and profits growth for the year 2018-19. Segment Revenue for FY19 grew by 88.7% Y-o-Y to Rs 130,566......